Effect of the molecular weight of poly(ε-caprolactone-co-DL-lactide) on toremifene citrate release from copolymer/silica xerogel composites

International Journal of Pharmaceutics

Volumn 212, Issue 1, 2001, Pages 121-130

  Rich, J ^a   Kortesuo, P ^b   Ahola, M ^c   Yli Urpo, A ^c   Kiesvaara, J ^b   Seppala J ^a  

^a AALTO UNIVERSITY   (Finland)

^b ORION CORPORATION   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Biodegradable polymers; Drug release; Poly( caprolactone co DL lactide); Silica xerogel; Toremifene citrate

Indexed keywords

COPOLYMER; DRUG CARRIER; POLYCAPROLACTONE; POLYLACTIDE; SILICA GEL; TOREMIFENE;

ARTICLE; CONTROLLED DRUG RELEASE; DISSOLUTION; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; GEL PERMEATION CHROMATOGRAPHY; HYDROLYSIS; MOLECULAR WEIGHT; PRIORITY JOURNAL; WATER ABSORPTION; WEIGHT REDUCTION;

ANTINEOPLASTIC AGENTS, HORMONAL; HYDROLYSIS; MOLECULAR WEIGHT; POLYESTERS; SILICON DIOXIDE; SOLUBILITY; TEMPERATURE; TIME FACTORS; TOREMIFENE;

EID: 0035808332     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(00)00601-3     Document Type: Article

References (19)

1. In vitro evaluation of biodegradable ε-caprolactone-co-D,L-lactide/silica xerogel composites containing toremifene citrate
2. Long-term evaluation of degradation and foreign-body reaction of subcutaneously implanted poly(DL-lactide-ε-caprolactone)
3. Properties of ε-caprolactone/ DL-lactide (ε-CL/DL-LA) copolymers with a minor ε-CL content
4. Biodegradable lactone copolymers. III. Mechanical properties of ε-caprolactone and lactide copolymers after hydrolysis in vitro
5. The role of transesterification in the polymerization of D,L-lactide and ε-caprolactone
6. Silica xerogel as an implantable carrier for controlled drug delivery - Evaluation of drug distribution and tissue effects after implantation
7. Removal pathway of silicon released from bioactive glass granules in vivo
8. Preparation and in vitro evaluation of biodegradable poly(ε-caprolactone-co-D,L lactide)(X-Y) devices containing trypanocidal drugs
9. Copolymers of 1,5-dioxepan-2-one and L- or D,L-dilactide: Hydrolytic degradation behaviour
10. Biodegradable lactone copolymers. II. Hydrolytic study of ε-caprolactone and lactide copolymers
11. Modification of the rates of chain cleavage of poly(ε-caprolactone) and related polyesters in the solid state
12. Sustained drug delivery systems. I. The permeability of poly(ε-caprolactone), poly(DL-lactic acid) and their copolymers
13. Poly-ε-caprolactone and its copolymers
14. Aliphatic polyesters II: The degradation of poly(DL-lactide), poly(ε-caprolactone), and their copolymers in vivo
15. Tissue reactions to controlled release silica xerogel carriers
16. Peptide, protein and vaccine delivery from implantable polymeric systems
17. The use of porous and surface modified silicas as drug delivery and stabilizing agent
18. In vitro evaluation of sustained drug release from biodegradable elastomer
19. Biodeterioration/biodegradation of polymeric medical devices in situ